What happens if PEN doesn't get regulatory approval to use the new low PH solution process? From the 27/10/17 update.
Following comprehensive technical reviews and analysis, the Company has concluded that the Lance operating performance under the current alkaline lixiviant process is unlikely to achieve the production rates and unit costs required for sustainable long-term commercial success at anything other than substantially increased uranium prices, and that the operating unit of the business would continue to rely on cash flow from nonproject related uranium purchases and sales.
What happens if PEN doesn't get regulatory approval to use the...
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PEN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.015(1.37%) |
Mkt cap ! $274.0M | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.12 | $1.08 | $237.1K | 216.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18320 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 4076 | 3 |
View Market Depth
| Last trade - 12.28pm 04/12/2024 (20 minute delay) ? |
| PEN (ASX) Chart |
